Cutera Stock

Cutera Equity

Delisted

The The Equity of Cutera (CUTRQ) as of Sep 9, 2026 is -171.83 M USD. In the previous year, The Equity was -15.20 M USD — a change of 1,030.46% (lower).

Equity

-171.83 MUSD

YoY

1,030.46%

Last updated:

In 2026, Cutera's equity was -171.83 M USD, a 1,030.46% increase from the -15.20 M USD equity in the previous year.

The Cutera Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2016
61.00 M USD
Jan 1, 2017
64.90 M USD
Jan 1, 2018
46.40 M USD
Jan 1, 2019
45.90 M USD
Jan 1, 2020
56.90 M USD
Jan 1, 2021
56.60 M USD
Jan 1, 2022
-15.20 M USD
Jan 1, 2023
-171.83 M USD
The Cutera Equity history
YEAREquityYoY
-171.83 MUSD+1,030.46%
-15.20 MUSD-126.86%
56.60 MUSD-0.53%
56.90 MUSD+23.97%
45.90 MUSD-1.08%
46.40 MUSD-28.51%
64.90 MUSD+6.39%
61.00 MUSD+22.00%
50.00 MUSD-37.89%
80.50 MUSD
Access this data via the Eulerpool API

Cutera Stock analysis

What does Cutera do? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Cutera's Equity

Cutera's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cutera's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cutera's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cutera's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cutera’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cutera stock

The Equity of Cutera is -171.83 M USD in 2026.

The Equity of Cutera changed from -15.20 M USD to -171.83 M USD, representing a 1,030.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Cutera since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Cutera historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Cutera

All Key Metrics — Cutera